Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp652
|
ENSMUSG00000075595.3 | zinc finger protein 652 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_95712491_95712843 | Zfp652 | 6 | 0.561355 | -0.49 | 1.5e-04 | Click! |
chr11_95719449_95719663 | Zfp652 | 6545 | 0.131878 | -0.44 | 8.4e-04 | Click! |
chr11_95712845_95713062 | Zfp652 | 58 | 0.687287 | -0.42 | 1.4e-03 | Click! |
chr11_95713248_95713730 | Zfp652 | 478 | 0.555512 | -0.23 | 8.6e-02 | Click! |
chr11_95712260_95712413 | Zfp652 | 337 | 0.531970 | -0.10 | 4.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_110814092_110814465 | 15.07 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
2 |
0.98 |
chr3_139860895_139861104 | 14.61 |
Gm43678 |
predicted gene 43678 |
48235 |
0.17 |
chr14_52010292_52011175 | 13.23 |
Zfp219 |
zinc finger protein 219 |
149 |
0.89 |
chr18_14320004_14320155 | 12.19 |
Gm29992 |
predicted gene, 29992 |
11197 |
0.17 |
chr3_34691996_34692370 | 11.94 |
Gm43206 |
predicted gene 43206 |
9550 |
0.13 |
chr11_42000751_42000937 | 11.27 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
13 |
0.99 |
chr5_131596672_131596823 | 11.08 |
Gm42589 |
predicted gene 42589 |
8657 |
0.12 |
chr2_106513126_106513315 | 10.65 |
Gm14015 |
predicted gene 14015 |
9883 |
0.26 |
chr12_26635257_26635560 | 10.51 |
1700020D12Rik |
RIKEN cDNA 1700020D12 gene |
33099 |
0.18 |
chr3_21810116_21810413 | 10.28 |
7530428D23Rik |
RIKEN cDNA 7530428D23 gene |
9491 |
0.28 |
chr13_83984413_83984945 | 10.23 |
Gm4241 |
predicted gene 4241 |
3312 |
0.25 |
chr1_132200403_132200699 | 10.08 |
Lemd1 |
LEM domain containing 1 |
412 |
0.74 |
chrX_102081931_102082285 | 10.05 |
Nhsl2 |
NHS-like 2 |
9166 |
0.13 |
chr11_35856326_35856649 | 9.65 |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
2933 |
0.25 |
chr2_84887072_84887267 | 9.43 |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
459 |
0.74 |
chr17_56472537_56473329 | 9.42 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
1694 |
0.3 |
chr10_69706157_69706324 | 9.38 |
Ank3 |
ankyrin 3, epithelial |
56 |
0.99 |
chr1_137900160_137900609 | 9.13 |
Gm4258 |
predicted gene 4258 |
1786 |
0.19 |
chr13_59927920_59928102 | 9.04 |
Gm48390 |
predicted gene, 48390 |
8573 |
0.16 |
chr14_39471537_39471713 | 8.87 |
Nrg3 |
neuregulin 3 |
1041 |
0.7 |
chr5_112520899_112521155 | 8.87 |
Sez6l |
seizure related 6 homolog like |
45900 |
0.1 |
chr12_12938393_12939271 | 8.70 |
Mycn |
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
1784 |
0.26 |
chr18_23877666_23877819 | 8.52 |
Gm23207 |
predicted gene, 23207 |
60371 |
0.08 |
chrX_105392310_105392478 | 8.43 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
618 |
0.71 |
chr2_146257146_146257347 | 8.27 |
A930019D19Rik |
RIKEN cDNA A930019D19 gene |
2040 |
0.28 |
chr16_77662305_77662524 | 8.27 |
9530003O04Rik |
RIKEN cDNA 9530003O04 gene |
7883 |
0.11 |
chr13_28947781_28947984 | 8.25 |
Sox4 |
SRY (sex determining region Y)-box 4 |
5831 |
0.23 |
chr8_91996683_91996834 | 8.17 |
Gm36843 |
predicted gene, 36843 |
836 |
0.56 |
chr1_43005870_43006021 | 8.08 |
Gpr45 |
G protein-coupled receptor 45 |
26115 |
0.14 |
chr6_113501820_113502073 | 8.06 |
Prrt3 |
proline-rich transmembrane protein 3 |
15 |
0.94 |
chr6_112885923_112886077 | 8.05 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
56541 |
0.1 |
chr6_56049196_56049347 | 8.00 |
Ppp1r17 |
protein phosphatase 1, regulatory subunit 17 |
31774 |
0.21 |
chr5_139537233_139537388 | 7.87 |
Uncx |
UNC homeobox |
6184 |
0.17 |
chr7_79498994_79499221 | 7.84 |
Mir9-3hg |
Mir9-3 host gene |
919 |
0.36 |
chr9_23011719_23011872 | 7.82 |
Bmper |
BMP-binding endothelial regulator |
211281 |
0.02 |
chr2_152024927_152025503 | 7.82 |
Slc52a3 |
solute carrier protein family 52, member 3 |
25318 |
0.12 |
chr5_53707391_53707723 | 7.77 |
Cckar |
cholecystokinin A receptor |
3 |
0.98 |
chr15_103519338_103519794 | 7.75 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4152 |
0.16 |
chr1_59516219_59516601 | 7.74 |
Gm973 |
predicted gene 973 |
146 |
0.94 |
chr12_31895375_31895526 | 7.54 |
Cog5 |
component of oligomeric golgi complex 5 |
1329 |
0.43 |
chr3_87970905_87971182 | 7.51 |
Nes |
nestin |
35 |
0.95 |
chr11_98959522_98960759 | 7.50 |
Rara |
retinoic acid receptor, alpha |
272 |
0.84 |
chr12_12710241_12710413 | 7.27 |
Gm25538 |
predicted gene, 25538 |
10288 |
0.16 |
chr7_4690491_4690723 | 7.19 |
Brsk1 |
BR serine/threonine kinase 1 |
3 |
0.94 |
chr2_16355572_16356406 | 7.03 |
Plxdc2 |
plexin domain containing 2 |
315 |
0.95 |
chr13_117602607_117603236 | 7.03 |
Hcn1 |
hyperpolarization activated cyclic nucleotide gated potassium channel 1 |
441 |
0.9 |
chr14_71963403_71963695 | 6.97 |
4930434J06Rik |
RIKEN cDNA 4930434J06 gene |
50458 |
0.18 |
chr1_19951138_19951319 | 6.83 |
Gm37315 |
predicted gene, 37315 |
114320 |
0.07 |
chrX_158923095_158923580 | 6.83 |
Gm5764 |
predicted gene 5764 |
89902 |
0.09 |
chr2_96585792_96585984 | 6.75 |
Lrrc4c |
leucine rich repeat containing 4C |
267672 |
0.02 |
chr13_16705709_16706238 | 6.63 |
Gm7537 |
predicted gene 7537 |
66483 |
0.13 |
chr8_33747412_33747586 | 6.56 |
Smim18 |
small integral membrane protein 18 |
271 |
0.88 |
chr2_70558554_70558705 | 6.49 |
Gad1 |
glutamate decarboxylase 1 |
3413 |
0.18 |
chr9_108825088_108825551 | 6.44 |
Gm37714 |
predicted gene, 37714 |
30 |
0.71 |
chr1_63272794_63272964 | 6.38 |
Gm11608 |
predicted gene 11608 |
236 |
0.53 |
chr7_87246354_87246961 | 6.30 |
Nox4 |
NADPH oxidase 4 |
8 |
0.98 |
chr5_37893640_37894032 | 6.13 |
Gm20052 |
predicted gene, 20052 |
64 |
0.98 |
chr14_55853343_55853626 | 6.11 |
Nynrin |
NYN domain and retroviral integrase containing |
526 |
0.61 |
chr7_62420605_62420845 | 5.96 |
Mkrn3 |
makorin, ring finger protein, 3 |
586 |
0.68 |
chr12_50967293_50967758 | 5.81 |
Gm40421 |
predicted gene, 40421 |
37348 |
0.16 |
chr3_154652985_154653307 | 5.77 |
Gm38139 |
predicted gene, 38139 |
3555 |
0.22 |
chr3_52009396_52009722 | 5.72 |
Gm37465 |
predicted gene, 37465 |
5534 |
0.14 |
chr15_56378637_56378788 | 5.70 |
Gm49213 |
predicted gene, 49213 |
36301 |
0.23 |
chr19_50457584_50457735 | 5.62 |
Sorcs1 |
sortilin-related VPS10 domain containing receptor 1 |
204981 |
0.02 |
chr11_112860810_112861146 | 5.57 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
35799 |
0.18 |
chr5_111944661_111945068 | 5.54 |
Gm42488 |
predicted gene 42488 |
629 |
0.81 |
chr2_159002966_159003144 | 5.47 |
Gm44319 |
predicted gene, 44319 |
66808 |
0.12 |
chr15_25416367_25416674 | 5.47 |
Gm48957 |
predicted gene, 48957 |
1457 |
0.31 |
chr10_64087128_64087425 | 5.46 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
2971 |
0.4 |
chr6_143359440_143359700 | 5.41 |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
73520 |
0.1 |
chr3_35405107_35405293 | 5.41 |
Gm43078 |
predicted gene 43078 |
8633 |
0.26 |
chr3_79416895_79417312 | 5.41 |
Fnip2 |
folliculin interacting protein 2 |
49102 |
0.13 |
chr7_18963281_18963503 | 5.38 |
Nanos2 |
nanos C2HC-type zinc finger 2 |
24008 |
0.07 |
chr3_101161643_101162203 | 5.37 |
Gm12486 |
predicted gene 12486 |
45476 |
0.11 |
chr10_45784349_45784500 | 5.37 |
D030045P18Rik |
RIKEN cDNA D030045P18 gene |
23138 |
0.18 |
chr1_24195078_24195281 | 5.23 |
Col9a1 |
collagen, type IX, alpha 1 |
8 |
0.98 |
chr2_21059725_21060081 | 5.21 |
Gm13376 |
predicted gene 13376 |
37196 |
0.16 |
chr13_51569697_51570174 | 5.19 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
448 |
0.86 |
chr1_126745016_126745301 | 5.15 |
Nckap5 |
NCK-associated protein 5 |
6956 |
0.32 |
chr10_95116795_95116987 | 5.08 |
Gm48868 |
predicted gene, 48868 |
512 |
0.77 |
chr1_132197589_132197740 | 4.98 |
Mir135b |
microRNA 135b |
424 |
0.73 |
chr1_98002942_98003123 | 4.95 |
Pam |
peptidylglycine alpha-amidating monooxygenase |
25777 |
0.16 |
chr5_81321396_81321547 | 4.94 |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
11446 |
0.29 |
chr7_91208180_91208332 | 4.89 |
Gm24552 |
predicted gene, 24552 |
34739 |
0.14 |
chr4_109342883_109343045 | 4.85 |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
95 |
0.97 |
chr9_45651157_45651308 | 4.81 |
Gm22069 |
predicted gene, 22069 |
16420 |
0.18 |
chr6_107529258_107529456 | 4.81 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
411 |
0.87 |
chr2_93956023_93956186 | 4.78 |
Gm13889 |
predicted gene 13889 |
945 |
0.48 |
chr15_56693269_56693466 | 4.72 |
Has2os |
hyaluronan synthase 2, opposite strand |
185 |
0.92 |
chr5_135508046_135508197 | 4.70 |
Hip1 |
huntingtin interacting protein 1 |
18863 |
0.13 |
chr12_3371136_3371295 | 4.66 |
Gm48511 |
predicted gene, 48511 |
2786 |
0.18 |
chr5_124350876_124351770 | 4.64 |
Cdk2ap1 |
CDK2 (cyclin-dependent kinase 2)-associated protein 1 |
331 |
0.81 |
chr9_16484808_16485485 | 4.58 |
Fat3 |
FAT atypical cadherin 3 |
16139 |
0.27 |
chr9_75683708_75684585 | 4.58 |
Scg3 |
secretogranin III |
90 |
0.96 |
chr10_33873025_33873176 | 4.57 |
Gm47935 |
predicted gene, 47935 |
82 |
0.95 |
chr14_55854785_55855698 | 4.54 |
Nynrin |
NYN domain and retroviral integrase containing |
1205 |
0.28 |
chr13_74391286_74391437 | 4.52 |
Zfp72 |
zinc finger protein 72 |
525 |
0.58 |
chr13_91093690_91093968 | 4.49 |
Atg10 |
autophagy related 10 |
31781 |
0.21 |
chr3_27862930_27863950 | 4.38 |
Gm26040 |
predicted gene, 26040 |
4673 |
0.26 |
chr2_46443413_46443655 | 4.37 |
Gm13470 |
predicted gene 13470 |
824 |
0.72 |
chr16_66651101_66651252 | 4.34 |
1700010K23Rik |
RIKEN cDNA 1700010K23 gene |
5942 |
0.34 |
chr3_31234057_31234208 | 4.33 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
24262 |
0.19 |
chr6_6869992_6870193 | 4.32 |
Dlx6os1 |
distal-less homeobox 6, opposite strand 1 |
1500 |
0.28 |
chr10_86425574_86426115 | 4.30 |
Syn3 |
synapsin III |
66053 |
0.08 |
chr4_84529275_84529457 | 4.27 |
Bnc2 |
basonuclin 2 |
4030 |
0.34 |
chr9_46316553_46316704 | 4.26 |
4931429L15Rik |
RIKEN cDNA 4931429L15 gene |
686 |
0.49 |
chr17_65772106_65773153 | 4.25 |
Rab31 |
RAB31, member RAS oncogene family |
11 |
0.98 |
chr1_141717637_141717788 | 4.25 |
Gm37604 |
predicted gene, 37604 |
171506 |
0.04 |
chr6_122764190_122764389 | 4.21 |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
15668 |
0.11 |
chr1_36493330_36493621 | 4.20 |
Gm47280 |
predicted gene, 47280 |
13087 |
0.09 |
chr9_9143140_9143315 | 4.18 |
Gm16833 |
predicted gene, 16833 |
93061 |
0.08 |
chr10_51011824_51012041 | 4.13 |
Sim1 |
single-minded family bHLH transcription factor 1 |
116281 |
0.06 |
chr16_22613603_22613754 | 4.10 |
Mir6362 |
microRNA 6362 |
8352 |
0.16 |
chr3_89337989_89338197 | 4.10 |
Efna4 |
ephrin A4 |
65 |
0.7 |
chr1_163574963_163575273 | 4.09 |
Gm29500 |
predicted gene 29500 |
32259 |
0.18 |
chr5_77838512_77838806 | 4.09 |
Gm42673 |
predicted gene 42673 |
70801 |
0.12 |
chr11_111658520_111658671 | 4.04 |
Gm11676 |
predicted gene 11676 |
45289 |
0.18 |
chr17_93202819_93203050 | 4.02 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
858 |
0.59 |
chr2_80616601_80616752 | 4.01 |
Dusp19 |
dual specificity phosphatase 19 |
369 |
0.58 |
chr7_44383953_44384694 | 3.97 |
Syt3 |
synaptotagmin III |
169 |
0.84 |
chr11_70029207_70029821 | 3.97 |
Dlg4 |
discs large MAGUK scaffold protein 4 |
11 |
0.93 |
chr15_88469626_88469777 | 3.96 |
Zdhhc25 |
zinc finger, DHHC domain containing 25 |
130601 |
0.05 |
chr3_118444063_118444214 | 3.95 |
Gm9916 |
predicted gene 9916 |
9368 |
0.15 |
chr4_33586619_33587267 | 3.94 |
Gm23304 |
predicted gene, 23304 |
42018 |
0.17 |
chr9_102692932_102693123 | 3.91 |
4930533D04Rik |
RIKEN cDNA 4930533D04 gene |
142 |
0.94 |
chr11_46848152_46848586 | 3.91 |
Gm12175 |
predicted gene 12175 |
26044 |
0.18 |
chr19_38398943_38399521 | 3.89 |
Slc35g1 |
solute carrier family 35, member G1 |
3191 |
0.2 |
chr6_85502458_85502847 | 3.89 |
Fbxo41 |
F-box protein 41 |
206 |
0.91 |
chr15_100761221_100761405 | 3.89 |
Slc4a8 |
solute carrier family 4 (anion exchanger), member 8 |
434 |
0.77 |
chr3_59005933_59006738 | 3.85 |
Med12l |
mediator complex subunit 12-like |
152 |
0.52 |
chr16_72698959_72699110 | 3.84 |
Robo1 |
roundabout guidance receptor 1 |
35830 |
0.24 |
chr4_115905730_115906018 | 3.82 |
6430628N08Rik |
RIKEN cDNA 6430628N08 gene |
15208 |
0.11 |
chr7_28837896_28838090 | 3.81 |
Lgals4 |
lectin, galactose binding, soluble 4 |
2057 |
0.15 |
chr2_168524621_168525987 | 3.78 |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
26972 |
0.2 |
chrX_72655463_72655614 | 3.74 |
Gabra3 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
648 |
0.7 |
chr18_9216061_9216288 | 3.71 |
Fzd8 |
frizzled class receptor 8 |
4011 |
0.28 |
chr11_112872749_112872978 | 3.66 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
47684 |
0.15 |
chr8_27877983_27878134 | 3.65 |
Gm24202 |
predicted gene, 24202 |
116947 |
0.06 |
chr17_25561859_25562047 | 3.64 |
Gm50026 |
predicted gene, 50026 |
740 |
0.43 |
chr2_51566911_51567062 | 3.62 |
Gm13494 |
predicted gene 13494 |
22011 |
0.18 |
chr8_3672203_3672802 | 3.61 |
Gm39121 |
predicted gene, 39121 |
72 |
0.57 |
chr8_122804269_122804471 | 3.58 |
Gm45743 |
predicted gene 45743 |
21716 |
0.09 |
chr10_119691512_119691869 | 3.56 |
Grip1 |
glutamate receptor interacting protein 1 |
364 |
0.88 |
chr1_157243724_157243889 | 3.53 |
Rasal2 |
RAS protein activator like 2 |
684 |
0.75 |
chr14_22505891_22506190 | 3.51 |
4930405A10Rik |
RIKEN cDNA 4930405A10 gene |
36758 |
0.18 |
chr4_135166441_135166836 | 3.51 |
Runx3 |
runt related transcription factor 3 |
12202 |
0.17 |
chr6_7969492_7969643 | 3.49 |
Rnps1-ps |
RNA binding protein with serine rich domain 1, pseudogene |
13816 |
0.21 |
chr1_153704179_153704462 | 3.48 |
5530400K19Rik |
RIKEN cDNA 5530400K19 gene |
10334 |
0.11 |
chr3_52045327_52045498 | 3.45 |
C130089K02Rik |
RIKEN cDNA C130089K02 gene |
18832 |
0.12 |
chr15_64382892_64383311 | 3.40 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
182 |
0.95 |
chr6_58903213_58903713 | 3.40 |
Herc3 |
hect domain and RLD 3 |
1715 |
0.32 |
chr11_69410509_69411506 | 3.39 |
Kdm6b |
KDM1 lysine (K)-specific demethylase 6B |
2668 |
0.12 |
chr8_40962802_40962972 | 3.38 |
Pdgfrl |
platelet-derived growth factor receptor-like |
36654 |
0.12 |
chr1_162015574_162015742 | 3.38 |
2810442N19Rik |
RIKEN cDNA 2810442N19 gene |
10486 |
0.15 |
chr2_70566463_70566614 | 3.37 |
Gad1 |
glutamate decarboxylase 1 |
161 |
0.93 |
chr7_138940326_138940493 | 3.36 |
Jakmip3 |
janus kinase and microtubule interacting protein 3 |
321 |
0.84 |
chr11_84701705_84702192 | 3.36 |
1700109G15Rik |
RIKEN cDNA 1700109G15 gene |
18484 |
0.2 |
chr2_125723315_125724104 | 3.34 |
Shc4 |
SHC (Src homology 2 domain containing) family, member 4 |
322 |
0.9 |
chr2_146062065_146062229 | 3.33 |
Cfap61 |
cilia and flagella associated protein 61 |
14896 |
0.25 |
chr5_37245988_37246869 | 3.33 |
Crmp1 |
collapsin response mediator protein 1 |
583 |
0.76 |
chr11_55608662_55608813 | 3.29 |
Glra1 |
glycine receptor, alpha 1 subunit |
539 |
0.8 |
chr8_104301612_104301969 | 3.29 |
Cmtm1 |
CKLF-like MARVEL transmembrane domain containing 1 |
8242 |
0.08 |
chr15_60822029_60822653 | 3.27 |
9930014A18Rik |
RIKEN cDNA 9930014A18 gene |
70 |
0.97 |
chr6_103382001_103382152 | 3.26 |
Gm44295 |
predicted gene, 44295 |
102090 |
0.07 |
chr17_90061012_90061180 | 3.25 |
Nrxn1 |
neurexin I |
27044 |
0.24 |
chr4_35845158_35845795 | 3.25 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
272 |
0.96 |
chr1_143640376_143640632 | 3.24 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
77 |
0.62 |
chr8_54736786_54736937 | 3.23 |
Wdr17 |
WD repeat domain 17 |
12357 |
0.21 |
chr2_80404996_80405147 | 3.22 |
Gm13752 |
predicted gene 13752 |
10174 |
0.19 |
chr7_18962876_18963247 | 3.20 |
Nanos2 |
nanos C2HC-type zinc finger 2 |
24339 |
0.07 |
chr3_117788910_117789089 | 3.19 |
Snx7 |
sorting nexin 7 |
42275 |
0.17 |
chr9_120619678_120620270 | 3.15 |
Gm39456 |
predicted gene, 39456 |
325 |
0.85 |
chr5_22095017_22095168 | 3.13 |
Reln |
reelin |
39577 |
0.17 |
chr13_94595731_94595885 | 3.12 |
Gm36991 |
predicted gene, 36991 |
23472 |
0.16 |
chr16_15295283_15295680 | 3.11 |
Gm21897 |
predicted gene, 21897 |
21977 |
0.21 |
chr3_105538840_105539458 | 3.09 |
Gm43847 |
predicted gene 43847 |
36242 |
0.16 |
chr2_20547240_20547391 | 3.09 |
Etl4 |
enhancer trap locus 4 |
665 |
0.81 |
chr7_27336270_27336758 | 3.08 |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
1178 |
0.32 |
chr11_88585153_88585378 | 3.08 |
Msi2 |
musashi RNA-binding protein 2 |
4882 |
0.29 |
chr19_45717981_45718173 | 3.07 |
Fgf8 |
fibroblast growth factor 8 |
24607 |
0.12 |
chr10_93261990_93262529 | 3.06 |
Cdk17 |
cyclin-dependent kinase 17 |
23236 |
0.16 |
chr4_35126883_35127034 | 3.00 |
Ifnk |
interferon kappa |
25098 |
0.16 |
chr7_119861501_119861661 | 2.99 |
Dcun1d3 |
DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) |
223 |
0.91 |
chr17_74994018_74994284 | 2.98 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
11417 |
0.21 |
chr1_64304647_64304805 | 2.97 |
Gm28981 |
predicted gene 28981 |
1683 |
0.47 |
chr19_47330666_47331291 | 2.96 |
Sh3pxd2a |
SH3 and PX domains 2A |
16227 |
0.18 |
chr4_24897458_24898170 | 2.96 |
Ndufaf4 |
NADH:ubiquinone oxidoreductase complex assembly factor 4 |
269 |
0.92 |
chr8_103347528_103347978 | 2.96 |
1600027J07Rik |
RIKEN cDNA 1600027J07 gene |
219 |
0.96 |
chr4_13421765_13421916 | 2.91 |
Gm11819 |
predicted gene 11819 |
22930 |
0.24 |
chr10_46922643_46922794 | 2.88 |
Gm47562 |
predicted gene, 47562 |
66216 |
0.12 |
chr1_81608809_81608960 | 2.85 |
Gm6198 |
predicted gene 6198 |
51401 |
0.16 |
chr12_80021102_80021412 | 2.85 |
Gm8275 |
predicted gene 8275 |
41406 |
0.12 |
chr2_19455988_19456139 | 2.84 |
1810010K12Rik |
RIKEN cDNA 1810010K12 gene |
3593 |
0.16 |
chr8_12805061_12805212 | 2.83 |
Atp11a |
ATPase, class VI, type 11A |
6280 |
0.17 |
chr10_74848484_74848651 | 2.79 |
Gm6419 |
predicted gene 6419 |
14849 |
0.22 |
chr1_63246947_63247570 | 2.78 |
1700039I01Rik |
RIKEN cDNA 1700039I01 gene |
1241 |
0.29 |
chr5_126335674_126335842 | 2.77 |
Gm23151 |
predicted gene, 23151 |
53896 |
0.16 |
chr4_154599885_154600298 | 2.77 |
Gm13134 |
predicted gene 13134 |
1106 |
0.45 |
chr14_32825463_32825851 | 2.76 |
Fam170b |
family with sequence similarity 170, member B |
8305 |
0.18 |
chr8_73142666_73143044 | 2.74 |
Gm22532 |
predicted gene, 22532 |
32403 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.7 | 10.6 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
2.1 | 6.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.6 | 15.6 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
1.5 | 6.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.5 | 4.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.4 | 5.8 | GO:0060596 | mammary placode formation(GO:0060596) |
1.4 | 4.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.3 | 10.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.9 | 2.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.9 | 3.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.9 | 4.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.8 | 2.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.8 | 4.8 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 2.2 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.7 | 2.2 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.7 | 2.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.7 | 2.6 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.6 | 1.9 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 1.9 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.6 | 1.9 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.6 | 1.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 6.0 | GO:0060013 | righting reflex(GO:0060013) |
0.5 | 2.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.5 | 2.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.5 | 6.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.5 | 1.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 3.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 1.7 | GO:0051794 | regulation of catagen(GO:0051794) |
0.4 | 1.3 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 2.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 5.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.4 | 1.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.4 | 1.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 2.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 3.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 1.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.3 | 1.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.3 | 1.0 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.3 | 1.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.3 | 1.0 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.3 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.3 | 0.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.9 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.3 | 1.5 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.3 | 0.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 0.8 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 0.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.3 | 0.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 2.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 1.0 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.2 | 0.7 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.2 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 3.5 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.2 | 3.8 | GO:0090382 | phagosome maturation(GO:0090382) |
0.2 | 0.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 3.1 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.2 | 2.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 6.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 0.8 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 6.8 | GO:0031103 | axon regeneration(GO:0031103) |
0.2 | 1.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.2 | 1.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.2 | 0.4 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.2 | 1.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 0.2 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.2 | 1.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.2 | 0.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 1.5 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.6 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 2.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.3 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.6 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.6 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 4.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 1.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.4 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 1.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 2.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 1.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 1.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 1.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.1 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.9 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 1.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 1.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 1.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.1 | 0.4 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.8 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.3 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.1 | 0.2 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 2.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 1.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 2.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 2.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 1.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 3.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.1 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 1.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.1 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.1 | 2.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.1 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.1 | 2.4 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.1 | 0.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.2 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.2 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.2 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.4 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 0.2 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.2 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.2 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.3 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.0 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.0 | 0.2 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.0 | 0.4 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.0 | 0.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.0 | 1.0 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.0 | GO:0048143 | astrocyte activation(GO:0048143) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 2.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.7 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.2 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.0 | 0.0 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.0 | 0.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.0 | 0.0 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.0 | 0.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 0.2 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 3.3 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.0 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 1.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.0 | 0.1 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.0 | 0.0 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.0 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.0 | 0.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.2 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 2.4 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.1 | GO:0051665 | positive regulation of Rac protein signal transduction(GO:0035022) membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.0 | 1.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.3 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.0 | 0.0 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.0 | 0.1 | GO:0051126 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.0 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.0 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.0 | 0.1 | GO:0060324 | face development(GO:0060324) |
0.0 | 0.2 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.0 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0014857 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.0 | 0.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.4 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.1 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.0 | 0.0 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.0 | 0.1 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.0 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.3 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.0 | 0.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.2 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.0 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.0 | 0.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 1.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.0 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.0 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.0 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.0 | 0.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.0 | 0.0 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.0 | 0.0 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.0 | 0.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.0 | 0.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.5 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.0 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.0 | GO:1902074 | response to salt(GO:1902074) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.0 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.0 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.0 | 0.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.0 | 0.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.2 | GO:0045191 | regulation of isotype switching(GO:0045191) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.0 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.0 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.0 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.0 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.0 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.0 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.2 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.0 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.5 | 9.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 13.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.7 | 4.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 5.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 4.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 6.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 1.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.3 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 4.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 3.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 2.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 2.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 2.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 2.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 3.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 0.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 1.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 7.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 3.2 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 3.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 3.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.0 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 1.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 13.5 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 4.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.1 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.1 | 1.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.2 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 4.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.5 | GO:0070187 | telosome(GO:0070187) |
0.1 | 1.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 5.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.6 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 5.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.6 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 1.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 1.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 5.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 1.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 2.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.0 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 3.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.0 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.0 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 14.2 | GO:0003680 | AT DNA binding(GO:0003680) |
1.5 | 4.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 4.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.2 | 6.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.2 | 6.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 9.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.0 | 7.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.7 | 13.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.7 | 2.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.7 | 2.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.6 | 6.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.6 | 6.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 1.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 2.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.5 | 1.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.5 | 2.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.5 | 1.4 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 2.6 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 1.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 4.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 3.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 2.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 1.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 3.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.3 | 1.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 4.0 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 0.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 7.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 2.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 2.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 5.6 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 2.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.2 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 2.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 3.0 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 7.8 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.4 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.2 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.8 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 1.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 3.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 3.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 0.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 1.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 2.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.2 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.5 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 1.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 5.8 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.2 | GO:0034793 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 2.3 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.9 | GO:0034945 | dihydrolipoamide branched chain acyltransferase activity(GO:0004147) palmitoleoyl [acyl-carrier-protein]-dependent acyltransferase activity(GO:0008951) serine O-acyltransferase activity(GO:0016412) O-succinyltransferase activity(GO:0016750) sinapoyltransferase activity(GO:0016752) O-sinapoyltransferase activity(GO:0016753) peptidyl-lysine N6-myristoyltransferase activity(GO:0018030) peptidyl-lysine N6-palmitoyltransferase activity(GO:0018031) benzoyl acetate-CoA thiolase activity(GO:0018711) 3-hydroxybutyryl-CoA thiolase activity(GO:0018712) 3-ketopimelyl-CoA thiolase activity(GO:0018713) N-palmitoyltransferase activity(GO:0019105) acyl-CoA N-acyltransferase activity(GO:0019186) protein-cysteine S-myristoyltransferase activity(GO:0019705) glucosaminyl-phosphotidylinositol O-acyltransferase activity(GO:0032216) ergosterol O-acyltransferase activity(GO:0034737) lanosterol O-acyltransferase activity(GO:0034738) naphthyl-2-oxomethyl-succinyl-CoA succinyl transferase activity(GO:0034848) 2,4,4-trimethyl-3-oxopentanoyl-CoA 2-C-propanoyl transferase activity(GO:0034851) 2-methylhexanoyl-CoA C-acetyltransferase activity(GO:0034915) butyryl-CoA 2-C-propionyltransferase activity(GO:0034919) 2,6-dimethyl-5-methylene-3-oxo-heptanoyl-CoA C-acetyltransferase activity(GO:0034945) L-2-aminoadipate N-acetyltransferase activity(GO:0043741) keto acid formate lyase activity(GO:0043806) azetidine-2-carboxylic acid acetyltransferase activity(GO:0046941) peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) acetyl-CoA:L-lysine N6-acetyltransferase(GO:0090595) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 2.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 5.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 1.0 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.0 | 0.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 0.0 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.3 | GO:0044105 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.0 | GO:0018571 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.0 | 0.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.0 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 6.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 5.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 3.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 2.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 6.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 5.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 3.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 6.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 6.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 4.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 7.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.0 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 13.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.6 | 11.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 4.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 4.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 2.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 4.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 3.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 13.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 2.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 4.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 5.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.1 | 7.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 1.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |